检索
AI 对话
AI 辅写
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Real-World Evidence of Improved Patient Outcomes with Reslizumab in Adults with Severe Eosinophilic Asthma: A Subgroup Analysis of Patients Receiving Reslizumab for More Than 12 Months

M. Wechsler,S. P. Peters,B. E. Chipps,T. Hill, R. Ariely,M. DePietro, M. Driessen,E. Terasawa,D. Thomason, R. A. Panettieri

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2020）

引用 0|浏览14
暂无评分
关键词
severe eosinophilic asthma,reslizumab,improved patient outcomes,real-world
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要